233554 COCO, Mouse, Recombinant
Produits recommandés
Aperçu
Replacement Information |
---|
Tableau de caractéristiques principal
Purity |
---|
≥90% by SDS-PAGE |
Product Information | |
---|---|
Form | Solid |
Formulation | Lyophilized from 0.2 µm filter-sterilized Acetonitrile, TFA, and BSA. |
Applications |
---|
Biological Information | |
---|---|
Biological activity | ED₅₀ = 0.6-3 µg/ml as determined by inhibition of BMP-4-induced activity (50 ng/ml BMP-4) in MC3T3-E1 mouse osteoblastic cells. |
Purity | ≥90% by SDS-PAGE |
Physicochemical Information | |
---|---|
Contaminants | Endotoxin: <1.0 EU/µg protein |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Référence | GTIN |
233554 | 0 |
Documentation
COCO, Mouse, Recombinant Certificats d'analyse
Titre | Numéro de lot |
---|---|
233554 |
Références bibliographiques
Aperçu de la référence bibliographique |
---|
Vonica, A. and A.H. Brivanlou 2007. Dev. Biol. 303, 281. Baron, M.H. 2005. Exp. Hematol. 33, 1015. Katoh, M. and M. Katoh 2005. Int. J. Mol. Med. 15, 885. Kishigami, S. and Y. Mishina 2005. Cytokine Growth Factor Rev. 16, 265. AvsianKretchmer, O. and A.J.W. Hsueh 2004. Mol. Endocrinol. 18, 1. De Robertis, E.M. and H. Koruda 2004. Annu. Rev. Cell Dev. Biol. 20, 285. Katoh, M. and M. Katoh 2004. Oncol. Rep. 12, 423. Bell, E. et al. 2003. Development 130, 1381. Pearce, J.J. et al. 1999. Dev. Biol. 209, 98. |